Clinical Trials Directory

Trials / Completed

CompletedNCT00004834

Randomized Study of Cognitive-Behavioral Therapy vs Imipramine and Their Combination for Panic Disorder

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
326 (planned)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVES: I. Determine which treatment is most effective for patients with panic disorder: cognitive-behavioral therapy (CBT) plus imipramine (IMI), CBT plus placebo, CBT alone, IMI alone, or placebo alone.

Detailed description

PROTOCOL OUTLINE: This is a randomized, double-blind, placebo-controlled study. Patients are randomized to receive one of five treatments: cognitive-behavioral therapy (CBT) alone, imipramine plus medical management (IMI), CBT plus IMI, pill placebo plus medical management (PLA), or CBT plus PLA. Patients are seen by therapists for 11 sessions over 12 weeks (3 sessions during days 1-10 followed by 6 weekly sessions and 2 biweekly sessions). Each CBT session lasts approximately 1 hour, each IMI session lasts approximately 30 minutes, and patients in combined treatment see 2 therapists for a total of about 80 minutes. Oral IMI or placebo is taken daily. Patients not responding to placebo or IMI after the initial 12 weeks are offered alternative treatment for up to 3 months or given a referral; responders continue to be treated monthly for the next 6 months. This is followed by a washout period of 6 months, after which patients receive final assessment. All therapy and assessment sessions are video- or audiotaped. Patients are interviewed by an independent evaluator at the start of treatment and 3, 9, and 15 months later, and must keep a set of weekly self-monitoring forms. In addition, patients complete rating forms and questionnaires, and undergo carbon dioxide measurement at the start of treatment and 3, 9, and 15 months later. At study conclusion, patients are told which medication they received and receive treatment recommendations.

Conditions

Interventions

TypeNameDescription
DRUGimipramine
BEHAVIORALcognitive-behavioral therapy

Timeline

Start date
1998-05-01
Primary completion
2005-06-01
Completion
2005-06-01
First posted
2000-02-25
Last updated
2013-02-21

Source: ClinicalTrials.gov record NCT00004834. Inclusion in this directory is not an endorsement.